Navigation Links
neXante Turns Apple's iPhone Into Skin Cancer Surveillance Support Tool And Health Record
Date:5/19/2010

s and records.

The neXante Skin Cancer Surveillance Support Suite comprises applications titled xBCC Skin, xSCC Skin, and xMM skin, respectively on Basal Cell Cancer, Squamous Cell Cancer, and Malignant Melanoma of the skin. Each application has neXante's DermTracker, a customized electronic health record that not only tracks and stores images of the skin, but also allows for recording the diagnosis, pathology, and treatment of each skin lesion.

neXante medical resources enable healthcare consumers to improve the quality of care, reduce costs, increase efficiencies and reduce medical errors while actively engaging individuals to improve their personal health.

About Bright 50

Bright 50 is a healthcare application developer for mobile devices. Bright 50's neXante service educates, enables, and empowers healthcare consumers to become engaged in their health by delivering medical information in an intuitive and interactive manner that supports individual engagement. Bright 50 is a privately held company headquartered in Redmond, Washington. For more information on neXante services go to http://www.nexante.com/. Media contact:pr(at)nexante(dot)com.

###

Read the full story at http://www.prweb.com/releases/nexante/iPhoneSkinCancerApps/prweb4020764.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. The Love Convention Returns With "Something New" at Hotel Arista on Valentines Weekend
2. Identified: Switch that turns on allergic disease in people
3. Biggest Loser Contestant Turns to PlasticSurgeryPortal Doctor to Complete Makeover
4. Movie Turns Into a Growing Movement to Reach Hurting Teens.
5. Effort to Regenerate Injured Spinal Cords Turns to a New Model
6. PACE Race Returns with Denver's Rudolph Ramble
7. 18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact
8. Panel Intelligence Returns to MedPanel Name
9. Wheelchairs for Warriors Returns for 2010 Gasparilla Marathon
10. Former Bank Negotiator Turns On Bank and is Approved by the Department of Real Estate
11. Manduka Turns up the Heat With Introduction of eQua(TM) Hot Yoga Towel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... In a continuing effort to remain ... Per Wickstrom, the founder of Choices Recovery in South ... “Salute to the Oscars” celebration held on February ... floor of the luxurious Beverly Hilton Hotel. , ... sustainable product placement in TV and film, this daylong ...
(Date:5/4/2015)... York (PRWEB) May 04, 2015 Takeda ... $2.4 billion to settle thousands of Actos lawsuits ( ... medication increases the risk that a patient will develop ... April 28th, if 95% of those eligible for the ... nearly 9,000 bladder cancer cases currently pending in courts ...
(Date:5/4/2015)... SAN DIEGO, California (PRWEB) May 04, 2015 ... health plans to manage their health is critical to ... patient satisfaction and reducing costs, but this will require ... spectrum. This change also demands that health systems move ... to speakers who took part in the third live ...
(Date:5/4/2015)... 2015 TROY Healthcare Solutions is proud ... Regional User Group (RUG) Conference in Baltimore, MD from ... Regional User Group provides an opportunity for clients to ... exhibitor gallery. , In addition to sponsoring the event, ... North Atlantic RUG Conference. Attendees can stop by the ...
(Date:5/4/2015)... 04, 2015 The opportunity for children to ... are the motivating forces behind The Fairy Godmother Next Door, ... author Amy L. Stark. , The inspiration for the enchanting ... door comes from Stark’s desire to be a fairy godmother. ... fairy godmother to my neighbors’ children since they were born. ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Interviews TV and Film Star Carolyn Hennesy About Substance Abuse and Treatment 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2
... Initiative (WHI) report show that hormone therapy is associated with ... well as an increased risk of developing invasive breast cancer ... and preventive medicine at the University at Buffalo and one ... JAMA , says the breast cancers found in these ...
... a little-known variety of the grain that is the ... help soothe the inflammation involved in allergies, asthma, and other ... Agricultural and Food Chemistry . Mendel Friedman and colleagues ... benefits of eating black rice bran. Bran is the outer ...
... HealthDay Reporter , TUESDAY, Oct. 19 (HealthDay News) ... (CML) who decided to stop taking the cancer drug Gleevec ... The study, published online Oct. 19 in The ... that the drug might go beyond long-term cancer control and ...
... Jordan, 20 October 2010 Elsevier Middle East announces ... ( JIPH ) has been selected for inclusion in MEDLINE, ... Medicine (NLM). Citations for articles indexed, the indexing terms and ... PubMed ( www.pubmed.gov ). Indexing using the US National Library ...
... HealthDay Reporter , TUESDAY, Oct. 19 (HealthDay News) -- Not only ... breast cancer, new research finds, but it also ups the risk ... chances of dying. A study appearing in the Oct. 20 ... is at odds with previous observational studies that had suggested a ...
... TUESDAY, Oct. 19 (HealthDay News) -- Heavy alcohol and marijuana ... persist into adulthood, according to a new study. The ... scored lower than their abstinent peers on tests measuring a ... professor of psychiatry at the University of New Mexico School ...
Cached Medicine News:Health News:Hormone therapy increases invasive breast cancer and mortality, WHI 11-year follow up finds 2Health News:Some With Once-Deadly Leukemia Can Take a Break From Gleevec 2Health News:Some With Once-Deadly Leukemia Can Take a Break From Gleevec 3Health News:Study Shows HRT Even Riskier Than Thought 2Health News:Study Shows HRT Even Riskier Than Thought 3Health News:Binge Drinking, Pot Could Put Teens' Intellect at Risk: Study 2Health News:Binge Drinking, Pot Could Put Teens' Intellect at Risk: Study 3
(Date:5/4/2015)... 4, 2015 Southfield Capital, a ... announced today that it completed a dividend ... specializes in the development and multi-channel deployment ... and biotechnology industries. Through the ... half of their invested capital and secured ...
(Date:5/4/2015)... RadiologyAuction will have their first auction starting May ... at the end of the auction on May 27 ... Fuji Cr,s, Agfa and Sony, printers and GE portable ... imaging equipment will be available at later auctions each ... of buying and selling imaging equipment, the brokers at ...
(Date:5/4/2015)... VALLEY, Calif. , May 4, 2015 ... biologic for psoriasis, today announced that preclinical and mechanism ... session at the Society of Investigative Dermatology (SID) Annual ... Atlanta, in Atlanta, Georgia . ... is advancing the development of RON2315, a novel, low ...
Breaking Medicine Technology:Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2RadiologyAuction Announces Event Starting On May 5th 2Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2
... 25, 2007 - Reata,Pharmaceuticals, Inc. today announced ... company's Synthetic Triterpenoid programs in,the May 2007 ... The article, "Triterpenoids and rexinoids as multifunctional,agents ... by researchers,and Reata scientific collaborators from the ...
... - Introgen,Therapeutics, Inc. (NASDAQ:INGN) today announced the publication ... survival,pathway impacts the anticancer activity of INGN 241. ... tumor killing effects of,INGN 241 in cell culture ... Introgen and The University of Texas M. D. ...
Cached Medicine Technology:Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 2Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 3Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 4Preclinical Studies Identify Novel Approach for Enhancing the,Anticancer Activity of Introgen's INGN 241 2Preclinical Studies Identify Novel Approach for Enhancing the,Anticancer Activity of Introgen's INGN 241 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: